India Globalization Capital: Growing Revenue and Now CBD Drinks

India Globalization Capital

India Globalization Capital is a US-based pharmaceutical company. Based in Maryland, this stock has divided investors since it de-listed from the NYSE in October.

There's much to be intrigued about here though; CBD-infused drinks for one.

India Globalization Capital

India Globalization Capital runs two separate businesses, a legacy infrastructure business and a medical cannabis business. The medical cannabis side caused a lot of fuss. It is why the company had to de-list from the NYSE; reprimanded for changing its business model to something entirely different—medical cannabis.

It also caused skepticism within the industry; was IGCC just jumping on a bandwagon?

Love it or hate it, India Globalization Capital continues to see its stock gain.

IGCC Stock Movement

According to Reagents Global Market:

"In its past 30 trading days IGCC stock returned 76.60%. Over three months, it changed 472.41%. In one year it has changed 504.22% and within that year its 52-week high was 14.58 and its 52-week low was 0.36. [At present], IGC stock is 591.47% above its 52 Week Low."

>> CWBTF Stock: Will Auxly Cannabis Group Maintain January's Gains?

Investors can't seem to get enough of cannabis-related stocks. India Globalization Capital now develops cannabis-based therapies to treat Alzheimer's, pain, nausea, epilepsy, and Parkinson's disease. And as medical cannabis becomes more accepted and legal across the US, IGCC stock has seen interest soar.

Now, the company has said it will develop and commercialize a hemp/CBD infused energy drink.

CBD

CBD and energy drinks are an investor's holy-grail at present. The market is projected to hit almost $85 billion USD by 2025. The CBD market "represents a unique opportunity for the development and commercialization of a CBD-infused, sugar-free energy beverage” stated IGC CEO, Ram Mukunda.

So is IGCC sending doubters away with their tail between their legs? The company has a market cap of $18 million, "$6.4 million in the treasury, very little debt and small but growing revenues reporting $811k for the 3 months ended September 30th, 2018, up from $235k for the same period last year."

The numbers show that India Globalization Capital is growing and it has CBD-infused beverages in the pipeline. Currently selling for $0.37 USD on the OTC, IGCC stock could be an exciting stock to watch.

 

Featured Image: Twitter

If You Liked This Article Click To Share